Literature DB >> 24836302

[Listeriosis and pregnancy].

Caroline Charlier-Woerther1, Marc Lecuit2.   

Abstract

Listeria monocytogenes is a ubiquitous Gram-positive bacillus widespread in nature. It is responsible for febrile abortion and encephalitis in cattle. It survives and multiplies at 4°C and does not alter the taste of food. Listeria monocytogenes is able to cross 3 host barriers: the intestinal, blood-brain and placental barriers. Maternal infection is rare but still severe in France, with 30 to 50 annual cases. Maternal infection is frequently asymptomatic, or manifests as isolated fever, whereas fetal and neonatal infection is severe and have a poor prognosis, with up to 25-35 % fetal/neonatal mortality. Amoxicillin is the reference antibiotic for listeriosis treatment and should be administered to every pregnant patient with unexplained fever, particularly in case of consumption of at risk food. Prevention in pregnant women relies on adherence to strict diet recommendations such as reheating of leftovers until steaming and avoidance of unpasteurized dairy products, cold delicatessen, meat spreads and pâtés. Listeriosis is a notifiable disease in France.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24836302     DOI: 10.1016/j.lpm.2014.03.006

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

1.  Concerns, attitudes, beliefs and information seeking practices with respect to nutrition-related issues: a qualitative study in French pregnant women.

Authors:  Clélia M Bianchi; Jean-François Huneau; Gaëlle Le Goff; Eric O Verger; François Mariotti; Patricia Gurviez
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-12       Impact factor: 3.007

2.  Progesterone impairs antigen-non-specific immune protection by CD8 T memory cells via interferon-γ gene hypermethylation.

Authors:  Yushi Yao; Hui Li; Jie Ding; Yixin Xia; Lei Wang
Journal:  PLoS Pathog       Date:  2017-11-20       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.